U.S., Oct. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07215559) titled 'A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes' on Oct. 09.
Brief Summary: The purpose of this study is to investigate weight reduction with macupatide and eloralintide, alone or in combination, in adult participants with obesity or overweight and with type 2 diabetes. Participation in the study will last about 48 weeks.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Obesity
Overweight
Diabetes Mellitus, Type 2
Intervention:
DRUG: Macupatide
Administered SC
DRUG: Eloralintide
Administered SC
DRUG: Mac...